Sept 26 (Reuters) - AbbVie ( ABBV ) said on Thursday its
drug met the main goal in a late-stage trial in patients with
early Parkinson's disease.
(Reporting by Sriparna Roy in Bengaluru; Editing by Anil
D'Silva)